Areas of active exploration include: Gastrointestinal healing (e.g., IBD, ulcers, leaky gut) Neurodegenerative conditions (e.g., Parkinsons, Alzheimers) Vascular repair (e.g., post-stroke recovery) PTSD and mood disorders Spinal cord injury repair With its unique ability to bridge multiple systemsfrom vascular to neural to connective tissueBPC-157 holds promise in areas far beyond orthopedic healing
Phosphorylase kinase inhibition therapy in burns and scalds
Dosage and frequency of injections varies depending on the patient's condition
Image Credit: Roman Samborskyi, Shutterstock
Nuclear factor erythroid 2-related factor 2 (Nrf2) can reduce ferroptosis through stimulating the typical ferroptosis target genes expressions, such as ferritin heavy chain 1 (FTH1), quinone oxidoreductase 1 (NQO1), and heme oxygenase-1 (HO-1)
doi: 10.1016/j.jalz.2013.01.005, 10 DwivediD.MeghaK.MishraR.MandalP